Table 1.
Age of the children at the time of first vaccination in the European, African and Asian studies (total vaccinated cohort).
| Study | Group | <1 month n (%) | 1 month n (%) | 2 months n (%) | 3 months n (%) | 4 months n (%) |
|---|---|---|---|---|---|---|
| European | HRV | – | 230 (8.69) | 1743 (65.87) | 672 (25.40) | 1 (0.04) |
| Placebo | – | 123 (9.12) | 888 (65.88) | 337 (25.00) | 0 (0.00) | |
| African | HRV-3 D | 1 (0.06) | 1549 (93.82) | 101 (6.12) | – | – |
| HRV-2 D | 3 (0.18) | 1565 (95.02) | 79 (4.80) | – | – | |
| Placebo | 2 (0.12) | 1544 (94.09) | 95 (5.79) | – | – | |
| Asian | HRV | – | 286 (5.34) | 1912 (35.68) | 3154 (58.85) | 7 (0.13) |
| Placebo | – | 252 (4.71) | 1943 (36.32) | 3143 (58.76) | 11 (0.21) |
D = dose; HRV = human rotavirus vaccine.
n (%) = number (percentage) of children in the given category.